Detalhe da pesquisa
1.
Real-world data for precision cancer medicine-A European perspective.
Genes Chromosomes Cancer
; 62(9): 557-563, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852573
2.
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study.
Support Care Cancer
; 30(4): 3131-3140, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877613
3.
Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis.
BMC Pulm Med
; 22(1): 255, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35761214
4.
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Eur J Cancer
; 199: 113556, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271745
5.
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.
Clin Lung Cancer
; 24(7): e282-e290, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391339
6.
Recent advances in small cell lung cancer: the future is now?
Minerva Endocrinol (Torino)
; 47(4): 460-474, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331739
7.
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report.
Case Rep Oncol
; 14(1): 477-482, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976623
8.
Autoimmune-related encephalitis during treatment with nivolumab for advanced head and neck cancer: a case report.
Tumori
; 106(6): NP23-NP28, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851941
9.
Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial.
Trials
; 21(1): 352, 2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321565
10.
Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Front Immunol
; 10: 1755, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396240
11.
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Front Immunol
; 10: 1135, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31191526
12.
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies.
Oncol Res Treat
; 47(6): 306-311, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527447
13.
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers.
Oncol Res Treat
; 47(6): 312-315, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574467
14.
Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
Eur J Cancer
; : 114130, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789333
15.
Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis.
Results Immunol
; 5: 33-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26693395